Current Evidence In Therapeutic Hypothermia For Postcardiac Arrest Care

Table of Contents

 

1. Abstract
2. Case Presentations
3. Definition: Moderate Hypothermia
4. Critical Appraisal Of The Literature
5. Etiology And Pathophysiology: Postcardiac Arrest Syndrome
   1. Postcardiac Arrest Brain Injury
   2. Postcardiac Arrest Myocardial Injury
   3. Systemic Ischemic Reperfusion Response
6. Differential Diagnosis: Disease Management Considerations
7. Prehospital Care
8. Emergency Department Evaluation
9. Diagnostic Studies
10. Treatment
    1. Cooling Systems
       1. External Cooling Systems
       2. Internal Cooling Systems
    2. Cooling System Summary
    3. Induction
    4. Maintenance Phase
11. Critical Care Basics
    1. Shivering Response
12. Controversies
13. Disposition
    1. Rewarming
14. Summary
15. Risk Management Pitfalls For Therapeutic Hypothermia
16. Cost-Effective Strategies For Therapeutic Hypothermia
17. Case Conclusion
18. Clinical Pathway For The Application Of Therapeutic Hypothermia
19. Tables and Figures
    1. Table 1. Published Guidelines Specific To Therapeutic Hypothermia
    2. Table 2. Inclusion Criteria For Induced Hypothermia Must Have All
    3. Table 3. Exclusion Criteria For Induced Hypothermia
    4. Table 4. Common Laboratory Changes Associated With Induced Hypothermia
    5. Table 5. Common Cardiac Changes
    6. Table 6. Procedures Recommended For Hemodynamic Monitoring
20. Induced Hypothermia Protocol Example
21. References

Abstract

Cardiac arrest is one of the most intense clinical scenarios faced by the emergency clinician. The challenges are twofold: restarting spontaneous circulation and simultaneously attempting to find―and then reverse―the cause of the cardiac arrest. Chaos, confusion, fear, misinformation, and missing information are all common obstacles to managing the patient in cardiac arrest. To assist emergency clinicians in this situation, protocols such as Basic Life Support and Advanced Cardiovascular Life Support (ACLS) have been codified and refined in the past decade.^1-3 These protocols have helped clinicians to think in a clear and goal-oriented manner and lead to one of two clinical outcomes: If their efforts are unsuccessful, the patient will be pronounced dead. If their efforts are successful, however, they will oftentimes find themselves facing the question (though perhaps not openly admitting it) of, “Now what?”

With the return of spontaneous circulation (ROSC), one of the emergency clinician’s initial challenges has been met. The heart is spontaneously circulating blood. The second challenge of attempting to find and reverse the cause of the cardiac arrest remains, however; efforts now shift to these investigative ends while the emergency clinician simultaneously attempts to keep the newly resuscitated patient stable. Within the last several years, a more specific continuing treatment plan―beyond that of simple stability―has emerged. This plan is aimed at addressing the patient’s postarrest pathology, which includes the initial disease process that led to the cardiac arrest and the aftermath of the event.⁴

No organ system is exempt from the insult of cardiac arrest. Cardiac, neurologic, renal, and hepatic functions all suffer, not only from the momentary decrease in perfusion, but also from the massive inflammatory responses/cascades present during reperfusion.⁵ Historically, hypothermia has appeared to confer some degree of protection from these insults.⁶ Case reports of victims of cold water drowning who make full neurologic recoveries after having been in arrest for extended periods are well-known.^7-10 Brain death—or severe neurologic compromise—is an unfortunate and devastating result of cardiac arrest. This event undermines all prior efforts to save the patient. Although other organ systems can be compensated for, artificially circumscribed, or even replaced (as is the case with renal and liver failure after cardiac arrest), neurologic function must stand on its own. It can determine the extent to which the patient is functional, even despite a perfusing rhythm.

Simple speculation about the practice of inducing hypothermia after cardiac arrest, followed by intense and promising research, has led to its use for the specific purpose of improving neurologic outcomes.¹¹ A growing body of evidence¹² suggests that control of body temperature (ie, preventing hyperthermia and, more specifically, inducing hypothermia) should become the standard of care. Many emergency medical services (EMS) providers are also investigating the use of specific guidelines and procedural protocols for inducing hypothermia in postcardiac arrest patients.¹³ A wide variation still exists in the technical application of hypothermia therapy, however.

Case Presentations

The ring of the red notification phone breaks the relative calm of an otherwise typical Monday morning and heralds the arrival of a critically ill patient. The dispatcher announces that EMS is on the way with a 57-year-old man in cardiac arrest, with an ETA of 3 minutes. Shortly after preparations for their arrival are complete, EMS personnel enter with CPR in progress and the patient already intubated. As monitor/defibrillator attachment, ETT placement confirmation, additional IV access, and complete exposure of the patient occur, you hear more about the clinical scenario from EMS. Mr. I.C. is a 57-year-old male who was moving furniture when, as described by witnesses, he complained of difficulty catching his breath and a slight tightness in his chest. He began coughing violently, vomited once, gasped, and collapsed. Emergency medical services personnel state that they arrived approximately 20 minutes after the patient had collapsed, with CPR in progress. The patient was intubated in the field, and EMS reports that the initial rhythm was PEA. Upon the patient’s arrival in the ED, the rhythm is noted to be ventricular fibrillation. Defibrillation is attempted twice over the next 4 minutes, with concomitant administration of medications. During the next rhythm check, QRS complexes are noted on the monitor and a pulse is palpated. The patient has had a return of spontaneous circulation, apparently 50 minutes from onset of the arrest. As you initiate postresuscitation care, you consider the patient’s prognosis and wonder if he qualifies for therapeutic hypothermia; ie, will therapeutic hypothermia make a difference in his outcome?

Definition: Moderate Hypothermia

Early research suggested that at temperatures greater than 30°C (86°F), the benefits of hypothermia outweigh the risks of adverse effects, whereas temperatures less than 30°C (86°F) are associated with a greater incidence of more severe adverse effects.¹⁴ The goal temperature for hypothermia used most often in studies showing improvement of outcomes was 32°C (90°F) to 33.9°C (93°F).^11,15 The literature has recently proposed that this range be referred to as moderate therapeutic hypothermia.¹⁶ The goal of this literature review is to assist the emergency clinician in adapting the known body of evidence and techniques into an easily applicable protocol to maximize outcomes after cardiac arrest. The online version of this issue includes the Mount Sinai Hospital Induced Hypothermia Protocol and Post- ROSC Care Package documents (available at www.ebmedicine.net/MSSMProtocol), which readers may find helpful in establishing institutional protocols.

Critical Appraisal Of The Literature

The MEDLINE® database was searched for articles published from 1950 to October 2010 that used the term hypothermia. This generalized search yielded well over 3000 publications. The effort was narrowed to English publications using 1 or more of the following terms: induced, therapeutic, cardiac arrest, heart, brain, emergency, resuscitation, and central nervous system. This search produced approximately 500 publications, which formed the basis for this review. Within this set, most of the publications involved either animal studies or small, human studies.

The greatest difficulty in searching the literature on hypothermia is the nature of the therapy. It is not a single intervention, but rather a combination of various interventions. Variations in inclusion/exclusion parameters, methodologies of cooling, goal temperatures, timing, and outcome measures are a major limitation to synthesizing the evidence.^17-19

The results of 2 landmark prospective randomized clinical trials published in 2002 established the foundation for inducing hypothermia in postcardiac arrest patients.^11,15 These 2 studies have been used as the basis for many of the recommendations and guidelines published in the last decade. (See Table 1.)

Risk Management Pitfalls For Therapeutic Hypothermia

1. “A patient has arrived from a nursing home with ROSC after being found unresponsive during the morning shift change. The patient is nonverbal and noninteractive, with little apparent cognitive ability secondary to a prior stroke. Am I obligated to induce hypothermia?” This practice is not the standard of care at this time; thus, the emergency clinician reserves the right to decide on a case-by-case basis which patients may or may not benefit from this therapy. The emergency clinician reserves the right to decide when clinical and/or extraclinical factors (such as resource allocation) make the application impractical.
2. “I was treating a patient with chest pain and a very concerning history when she suddenly arrested. After several minutes, we were able to bring her back. An ECG taken after the arrest showed lateral wall myocardial infarction. I activated the cath team, but should I have waited until the patient was cooled before letting her go for the procedure?” Treating a patient with induced hypothermia should not delay or inhibit the application of any other emergent procedures or investigations (eg, cardiac catheterization, surgical intervention, interventional radiology) related to the underlying pathology of cardiac arrest. Most times, the interventions can be performed simultaneously.
3. “As an emergency clinician, I’m excited about the prospect of having an additional therapy for my postcardiac arrest patients. I have all of the tools in my ED and would like to get started right away. What else do I need to do?” Therapeutic hypothermia is a multidisciplinary treatment modality; before initiation of any hypothermia protocol, all potential services that may be caring for the patients should be involved in the discussion. These services may include neurology, intensive care medicine, emergency medicine, and EMS.
4. “I’m called to the bedside by the nurse because the most recent ECG of a patient receiving therapeutic hypothermia appears to have a lot of artifact that she can’t seem to get rid of. On close inspection, the patient appears to have a fine tremor. The nurse asks if I would like to administer another dose of paralytic.” Paralysis should be used only as a last resort for shivering control, as masking seizure activity may result in worsening of neurologic status despite any benefits gained by therapeutic hypothermia. Sedation and analgesia should be used first.
5. “While working medical control for my local EMS system, I received a call about a patient postcardiac arrest with ROSC. The EMS providers stated that they had been training to perform hypothermia and asked if they should begin therapy before my assessment of the patient.” Emergency medical services are a vital part of the hypothermia care paradigm, as the therapy has been shown to be more effective when delivered early. The initial cooling process can be started easily in the field with ice or cooled saline. If the receiving emergency clinician does not feel that hypothermia care is warranted, then there is no obligation to continue it.
6. “The patient receiving therapeutic hypothermia suddenly went into atrial fibrillation. I decided to attempt cardioversion, and the first shock converted the patient to normal sinus rhythm. After several minutes, however, the atrial fibrillation returned. Then the patient’s blood pressure started falling.” The development of a life-threatening arrhythmia is a contraindication to hypothermia care. The patient should be rewarmed to normothermia.
7. “When using therapeutic hypothermia I continue to have difficulty maintaining a constant temperature. Every time I adjust the device or add saline to recool the patient, I end up overshooting my goal.” First and foremost, check the patient for shivering. Wide temperature swings are not the norm and may be a sign of occult or fine shivering. Second, consider a different placement for the particular feedback device. If possible, esophageal placement should be attempted.
8. “After several hours of stability during therapeutic hypothermia, my patient became gradually more tachycardic. Although she was initially weaned from pressors, her blood pressure started falling again. I used ultrasound only to find her IVC had collapsed, and her heart was pumping vigorously.” Cold will cause a diuresis. Although all patients may require some form of maintenance fluid, hypothermic patients should have urine output monitored closely and subsequently matched in return.
9. “While beginning to rewarm the patient, I noticed a change in the T wave morphology on the monitor. A subsequent ECG showed peaked T waves. Did I miss renal failure in the patient?” A too-rapid rate of rewarming will cause severe electrolyte shifts, particularly hyperkalemia. The rate of rewarming should not exceed 1°C (2°F) per hour and ideally should be more toward 0.5°C (1°F) per hour.
10. “A patient who has undergone hypothermia care is neurologically devastated several days after rewarming. I am asked why it did not work.” Hypothermia care offers no guarantees. Efforts should be made to explain to providers and family that this therapy will increase the patient’s chances for attaining a good neurologic outcome; however, it is difficult to predict which patients will fully recover on the basis of the available data.

Tables and Figures

References

Evidence-based medicine requires a critical appraisal of the literature based upon study methodology and number of subjects. Not all references are equally robust. The findings of a large, prospective, randomized, and blinded trial should carry more weight than a case report.

To help the reader judge the strength of each reference, pertinent information about the study, such as the type of study and the number of patients in the study, will be included in bold type following the reference, where available.

1. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Part I. Introduction. JAMA. 1992;268(16):2171-2183. (Practice guidelines)
2. ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2005;112(24 suppl):IV1-IV203. (Practice guidelines)
3. Chehardy P, Doherty A, Dracup K, et al. Cardiopulmonary resuscitation and emergency cardiovascular care: education. Ann Emerg Med. 2001;37(4 suppl):S49-S59. (Practice guidelines)
4. Negovsky VA. The second step in resuscitation--the treatment of the ‘post-resuscitation disease’. Resuscitation. 1972;1(1):1-7. (Review)
5. Neumar RW. Molecular mechanisms of ischemic neuronal injury. Ann Emerg Med. 2000;36(5):483-506. (Review)
6. Dietrich WD, Busto R, Alonso O, et al. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab. 1993;13(4):541-549. (Animal model)
7. Bolte RG, Black PG, Bowers RS, et al. The use of extracorporeal rewarming in a child submerged for 66 minutes. JAMA. 1988;260(3):377-379. (Case report)
8. Biggart MJ, Bohn DJ. Effect of hypothermia and cardiac arrest on outcome of near-drowning accidents in children. J Pediatr. 1990;117(2, pt 1):179-183. (Retrospective; 55 patients)
9. Tyndal CM Jr, Rose MW, McFalls RE, et al. Profound accidental hypothermia in the deep South: clinical experience. Perfusion. 1996;11(1):57-60. (Case report)
10. Lund FK, Torgersen JG, Flaatten HK. Heart rate monitored hypothermia and drowning in a 48-year-old man: survival without sequelae: a case report. Cases J. 2009;2:6204. (Case report)
11. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549-556. (Prospective, randomized, controlled; 273 patients)
12. Nolan JP, Morley PT, Vanden Hoek TL, et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation. 2003;108(1):118-121. (Practice guideline)
13. Mechem CC, Goodloe JM, Richmond NJ, et al; U.S. Metropolitan Municipalities EMS Medical Directors Consortium. Resuscitation center designation: recommendations for emergency medical services practices. Prehosp Emerg Care. 2010;14(1):51-61. doi:10.3109/10903120903349804. (Review)
14. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009;37(7 suppl):S186-S202. (Review)
15. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557-563. (Prospective, randomized, controlled; 77 patients)
16. Polderman KH, Herold I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med. 2009;37(3):1101-1120. (Review)
17. Liss HP. A history of resuscitation. Ann Emerg Med. 1986;15(1):65-72. (Review)
18. Varon J, Sternbach GL. Cardiopulmonary resuscitation: lessons from the past. J Emerg Med. 1991;9(6):503-507. (Review)
19. Varon J, Acosta P. Therapeutic hypothermia: past, present, and future. Chest. 2008;133(5):1267-1274. doi:10.1378/ chest.07-2190. (Review)
20. Castrén M, Silfvast T, Rubertsson S, et al. Scandinavian clinical practice guidelines for therapeutic hypothermia and postresuscitation care after cardiac arrest. Acta Anaesthesiol Scand. 2009;53(3):280-288. doi:10.1111/j.1399-6576.2008.01881.x. (Practice guidelines)
21. Canadian Association of Emergency Physicians, CAEP Critical Care Committee. Guidelines for the use of hypothermia after cardiac arrest. CJEM. 2006;8(2):106-108. (Practice guidelines)
22. Australian Resuscitation Council. Adult advanced life support: Australian Resuscitation Council guidelines 2006. Emerg Med Australas. 2006;18(4):337-356. doi:10.1111/j.1742- 6723.2006.00890.x. (Practice guidelines)
23. Peberdy MA, Callaway CW, Neumar RW, et al. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18 Suppl 3):S768-86. doi: 10.1161/CIRCULATIONAHA.110.971002 (Practice guidelines)
24. Negovsky VA, Gurvitch AM. Post-resuscitation disease--a new nosological entity: its reality and significance. Resuscitation. 1995;30(1):23-27. (Practice guidelines)
25. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation. 1989;80(4):1049-1062. (Review)
26. Neumar RW, Nolan JP, Adrie C, et al. Postcardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation. 2008;118(23):2452-2483. (Review, consensus statement)
27. Bano D, Nicotera P. Ca2+ signals and neuronal death in brain ischemia. Stroke. 2007;38(2 suppl):674-676. doi:10.1161/01. STR.0000256294.46009.29. (Review)
28. Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79(4):1431-1568. (Review)
29. Ames A III, Wright RL, Kowada M, et al. Cerebral ischemia, II: the no-reflow phenomenon. Am J Pathol. 1968;52(2):437- 453. (Animal model)
30. Böttiger BW, Krumnikl JJ, Gass P, et al. The cerebral ’noreflow’ phenomenon after cardiac arrest in rats--influence of low-flow reperfusion. Resuscitation. 1997;34(1):79-87. (Animal model)
31. Sundgreen C, Larsen FS, Herzog TM, et al. Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest. Stroke. 2001;32(1):128-132. (Prospective observational; 18 patients, 6 healthy controls)
32. Nishizawa H, Kudoh I. Cerebral autoregulation is impaired in patients resuscitated after cardiac arrest. Acta Anaesthesiol Scand. 1996;40(9):1149-1153. (Prospective observational; 8 patients)
33. Snyder JV, Nemoto EM, Carroll RG, et al. Global ischemia in dogs: intracranial pressures, brain blood flow and metabolism. Stroke. 1975;6(1):21-27. (Animal model)
34. Rivers EP, Wortsman J, Rady MY, et al. The effect of the total cumulative epinephrine dose administered during human CPR on hemodynamic, oxygen transport, and utilization variables in the postresuscitation period. Chest. 1994;106(5):1499-1507. (Prospective, nonrandomized, controlled trial of inception cohorts; 49 patients)
35. Prengel AW, Lindner KH, Ensinger H, et al. Plasma catecholamine concentrations after successful resuscitation in patients. Crit Care Med. 1992;20(5):609-614. (Prospective descriptive; 10 patients)
36. Kern KB. Postresuscitation myocardial dysfunction. Cardiol Clin. 2002;20(1):89-101. (Review)
37. Kern KB, Hilwig RW, Berg RA, et al. Postresuscitation left ventricular systolic and diastolic dysfunction: treatment with dobutamine. Circulation. 1997;95(12):2610-2613. (Animal model)
38. Laurent I, Monchi M, Chiche JD, et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol. 2002;40(12):2110-2116. (Prospective observational; 165 patients)
39. Kern KB, Hilwig RW, Rhee KH, et al. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol. 1996;28(1):232- 240. (Animal model)
40. Gando S, Nanzaki S, Morimoto Y, et al. Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury. Intensive Care Med. 2000;26(1):38-44. (Prospective observational; 44 patients, 8 healthy controls)
41. Geppert A, Zorn G, Karth GD, et al. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit Care Med. 2000;28(7):2360-2365. (Prospective observational; 25 patients, 7 controls)
42. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-likeˮ syndrome. Circulation. 2002;106(5):562-568. (Prospective observational; 11 patients)
43. Böttiger BW, Motsch J, Böhrer H, et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation. 1995;92(9):2572-2578. (Prospective observational; 23 patients)
44. Wolfson SK Jr, Safar P, Reich H, et al. Dynamic heterogeneity of cerebral hypoperfusion after prolonged cardiac arrest in dogs measured by the stable xenon/CT technique: a preliminary study. Resuscitation. 1992;23(1):1-20. (Animal model)
45. Hékimian G, Baugnon T, Thuong M, et al. Cortisol levels and adrenal reserve after successful cardiac arrest resuscitation. Shock. 2004;22(2):116-119. (Prospective observational; 33 patients)
46. Xu L, Yenari MA, Steinberg GK, et al. Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab. 2002;22(1):21-28. doi:10.1097/00004647-200201000-00003. (Animal model)
47. Adachi M, Sohma O, Tsuneishi S, et al. Combination effect of systemic hypothermia and caspase inhibitor administration against hypoxic-ischemic brain damage in neonatal rats. Pediatr Res. 2001;50(5):590-595. (Animal model)
48. Povlishock JT, Buki A, Koiziumi H, et al. Initiating mechanisms involved in the pathobiology of traumatically induced axonal injury and interventions targeted at blunting their progression. Acta Neurochir Suppl. 1999;73:15-20. (Animal model)
49. Batista LM, Lima FO, Januzzi JL Jr, et al. Feasibility and safety of combined percutaneous coronary intervention and therapeutic hypothermia following cardiac arrest. Resuscitation. 2010;81(4):398-403. doi:10.1016/j.resuscitation. 2009.12.016. (Prospective observational; 90 patients)
50. Parham W, Edelstein K, Unger B, et al. Therapeutic hypothermia for acute myocardial infarction: past, present, and future. Crit Care Med. 2009;37(7 suppl):S234-S237. doi:10.1097/CCM.0b013e3181ab311d. (Review)
51. Ly HQ, Denault A, Dupuis J, et al. A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study). Am Heart J. 2005;150(5):933. doi:10.1016/j. ahj.2005.02.049. (Prospective observational; 90 patients)
52. Kandzari DE, Chu A, Brodie BR, et al. Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study). Am J Cardiol. 2004;93(5):636-639. doi:10.1016/j.amj card.2003.11.038. (Prospective observational; 18 patients)
53. Dixon SR, Whitbourn RJ, Dae MW, et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002;40(11):1928-1934. (Randomized controlled; 42 patients)
54. Götberg M, Olivecrona GK, Koul S, et al. A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv. 2010;3(5):400-407. doi:10.1161/ CIRCINTERVENTIONS.110.957902. (Randomized controlled; 20 patients)
55. Schefold JC, Storm C, Joerres A, et al. Mild therapeutic hypothermia after cardiac arrest and the risk of bleeding in patients with acute myocardial infarction. Int J Cardiol. 2009;132(3):387-391. doi:10.1016/j.ijcard.2007.12.008. (Prospective observational; 31 patients)
56. O’Connor RE, Brady W, Brooks SC, et al. Part 10: acute coronary syndromes: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122(18 suppl 3):S787- S817. doi:10.1161/CIRCULATIONAHA.110.971028. (Practice guidelines)
57. Hovland A, Bjørnstad H, Hallstensen RF, et al. Massive pulmonary embolism with cardiac arrest treated with continuous thrombolysis and concomitant hypothermia. Emerg Med J. 2008;25(5):310-311. doi:10.1136/emj.2007.056390. (Case report)
58. Komotar RJ, Zacharia BE, Mocco J, et al. Controversies in the surgical treatment of ruptured intracranial aneurysms: the First Annual J. Lawrence Pool Memorial Research Symposium--controversies in the management of cerebral aneurysms. Neurosurgery. 2008;62(2):396-407; discussion 405- 407. doi:10.1227/01.neu.0000316006.26635.b0. (Consensus statement)
59. Fingas M, Clark DL, Colbourne F. The effects of selective brain hypothermia on intracerebral hemorrhage in rats. Exp Neurol. 2007;208(2):277-284. doi:10.1016/j.expneurol. 2007.08.018. (Animal model)
60. Todd MM, Hindman BJ, Clarke WR, et al; Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352(2):135-145. doi:10.1056/NEJMoa040975. (Prospective, randomized, controlled; 1001 patients)
61. Gasser S, Khan N, Yonekawa Y, et al. Long-term hypothermia in patients with severe brain edema after poor-grade subarachnoid hemorrhage: feasibility and intensive care complications. J Neurosurg Anesthesiol. 2003;15(3):240-248. (Prospective controlled; 156 patients)
62. Seule MA, Muroi C, Mink S, et al. Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm. Neurosurgery. 2009;64(1):86-92; discussion 92-93. doi:10.1227/01.NEU.0000336312.32773.A0. (Retrospective observational; 441 patients)
63. Adrie C, Laurent I, Monchi M, et al. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care. 2004;10(3):208-212. (Review)
64. Polderman KH. Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet. 2008;371(9628):1955-1969. (Review)
65. Schwab S, Georgiadis D, Berrouschot J, et al. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke. 2001;32(9):2033-2035. (Prospective observational; 50 patients)
66. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med. 1996;334(19):1209-1215. doi:10.1056/NEJM199605093341901. (Prospective, randomized, controlled; 200 patients)
67. Fischer E, Marano MA, Van Zee KJ, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 1992;89(5):1551-1557. doi:10.1172/JCI115748. (Animal model)
68. Ohlsson K, Björk P, Bergenfeldt M, et al. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990;348(6301):550-552. doi:10.1038/348550a0. (Animal model)
69. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330(6149):662-664. doi:10.1038/330662a0. (Animal model)
70. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985;229(4716):869-871. (Animal model)
71. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis. 2008;8(1):32-43. doi:10.1016/S1473- 3099(07)70265-7. (Review)
72. Eichacker PQ, Parent C, Kalil A, et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med. 2002;166(9):1197- 1205. (Meta-analysis)
73. Kuboyama K, Safar P, Radovsky A, et al. Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study. Crit Care Med. 1993;21(9):1348-1358. (Animal model)
74. Arrich J; European Resuscitation Council Hypothermia After Cardiac Arrest Registry Study Group. Clinical application of mild therapeutic hypothermia after cardiac arrest. Crit Care Med. 2007;35(4):1041-1047. doi:10.1097/01. CCM.0000259383.48324.35. (Practice guidelines)
75. Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation. 2007;73(1):29-39. (Prospective interventional; 119 patients)
76. Busch M, Soreide E, Lossius HM, et al. Rapid implementation of therapeutic hypothermia in comatose out-ofhospital cardiac arrest survivors. Acta Anaesthesiol Scand. 2006;50(10):1277-1283. doi:10.1111/j.1399-6576.2006.01147.x. (Prospective interventional; 27 patients)
77. Holzer M, Müllner M, Sterz F, et al. Efficacy and safety of endovascular cooling after cardiac arrest: cohort study and Bayesian approach. Stroke. 2006;37(7):1792-1797. doi:10.1161/01.STR.0000227265.52763.16. (Retrospective cohort; 1038)
78. Oddo M, Schaller MD, Feihl F, et al. From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Crit Care Med. 2006;34(7):1865-1873. (Retrospective cohort; 109 patients)
79. Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med. 1997;30(2):146-153. (Prospective interventional; 22 patients)
80. Rittenberger JC, Sangl J, Wheeler M, et al. Association between clinical examination and outcome after cardiac arrest. Resuscitation. 2010;81(9):1128-1132. doi:10.1016/j.resuscitation. 2010.05.011. (Retrospective; 272 patients)
81. Valeri CR, MacGregor H, Cassidy G, et al. Effects of temperature on bleeding time and clotting time in normal male and female volunteers. Crit Care Med. 1995;23(4):698-704. (Prospective observation; 54 patients)
82. Valeri CR, Feingold H, Cassidy G, et al. Hypothermiainduced reversible platelet dysfunction. Ann Surg. 1987;205(2):175-181. (Animal model)
83. Ying CL, Tsang SF, Ng KF. The potential use of desmopressin to correct hypothermia-induced impairment of primary haemostasis--an in vitro study using PFA-100. Resuscitation. 2008;76(1):129-133. doi:10.1016/j.resuscitation.2007.07.009. (Bench research)
84. Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med. 2007;35(9):2196-2204. (Review)
85. Lewis ME, Al-Khalidi AH, Townend JN, et al. The effects of hypothermia on human left ventricular contractile function during cardiac surgery. J Am Coll Cardiol. 2002;39(1):102-108. (Prospective observational; 10 patients)
86. Mattheussen M, Mubagwa K, Van Aken H, et al. Interaction of heart rate and hypothermia on global myocardial contraction of the isolated rabbit heart. Anesth Analg. 1996;82(5):975- 981. (Animal model)
87. Castrén M, Nordberg P, Svensson L, et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010;122(7):729-736. doi:10.1161/ CIRCULATIONAHA.109.931691. (Prospective, randomized, controlled; 194 patients)
88. Larsson IM, Wallin E, Rubertsson S. Cold saline infusion and ice packs alone are effective in inducing and maintaining therapeutic hypothermia after cardiac arrest. Resuscitation. 2010;81(1):15-19. doi:10.1016/j.resuscitation.2009.09.012. (Prospective interventional; 38 patients)
89. Merchant RM, Abella BS, Peberdy MA, et al. Therapeutic hypothermia after cardiac arrest: unintentional overcooling is common using ice packs and conventional cooling blankets. Crit Care Med. 2006;34(12 suppl):S490-S494. doi:10.1097/01. CCM.0000246016.28679.36. (Prospective observational; 32 patients)
90. Kämäräinen A, Virkkunen I, Tenhunen J, et al. Induction of therapeutic hypothermia during prehospital CPR using ice-cold intravenous fluid. Resuscitation. 2008;79(2):205-211. doi:10.1016/j.resuscitation.2008.07.003. (Prospective interventional; 17 patients)
91. Prunet B, Lacroix G, Bordes J, et al. Catheter related venous thrombosis with cooling and warming catheters: two case reports. Cases J. 2009;2:8857. doi:10.1186/1757-1626-0002- 0000008857. (Case report)
92. Simosa HF, Petersen DJ, Agarwal SK, et al. Increased risk of deep venous thrombosis with endovascular cooling in patients with traumatic head injury. Am Surg. 2007;73(5):461- 464. (Retrospective cohort; 11 patients)
93. Inderbitzen B, Yon S, Lasheras J, et al. Safety and performance of a novel intravascular catheter for induction and reversal of hypothermia in a porcine model. Neurosurgery. 2002;50(2):364-370. (Animal model)
94. Polderman KH, Rijnsburger ER, Peerdeman SM, et al. Induction of hypothermia in patients with various types of neurologic injury with use of large volumes of ice-cold intravenous fluid. Crit Care Med. 2005;33(12):2744-2751. (Prospective interventional; 134 patients)
95. Virkkunen I, Yli-Hankala A, Silfvast T. Induction of therapeutic hypothermia after cardiac arrest in prehospital patients using ice-cold Ringerʼs solution: a pilot study. Resuscitation. 2004;62(3):299-302. doi:10.1016/j.resuscitation. 2004.04.003. (Prospective observational; 13 patients)
96. Bernard S, Buist M, Monteiro O, et al. Induced hypothermia using large volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital cardiac arrest: a preliminary report. Resuscitation. 2003;56(1):9-13. (Prospective interventional; 22 patients)
97. Rajek A, Greif R, Sessler DI, et al. Core cooling by central venous infusion of ice-cold (4 degrees C and 20 degrees C) fluid: isolation of core and peripheral thermal compartments. Anesthesiology. 2000;93(3):629-637. (Prospective observational; 18 patients)
98. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296-327. doi:10.1097/01. CCM.0000298158.12101.41. (Practice guidelines)
99. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779-789. doi:10.1056/NEJMoa0907118. (Prospective, randomized, controlled; 1679 patients)
100. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377. doi:10.1056/NEJMoa010307. (Prospective, randomized, controlled; 263 patients)
101. Jain RK, Antonio BL, Bowton DL, et al. Variability in central venous pressure measurements and the potential impact on fluid management. Shock. 2010;33(3):253-257. doi:10.1097/ SHK.0b013e3181b2bb22. (Prospective observational; 100 patients)
102. Otero RM, Nguyen HB, Huang DT, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest. 2006;130(5):1579-1595. doi:10.1378/chest.130.5.1579. (Review)
103. Keller AS, Melamed R, Malinchoc M, et al. Diagnostic accuracy of a simple ultrasound measurement to estimate central venous pressure in spontaneously breathing, critically ill patients. J Hosp Med. 2009;4(6):350-355. doi: 10.1002/jhm.503. (Prospective observational; 63 patients)
104. Muller L, Louart G, Bousquet PJ, et al. The influence of the airway driving pressure on pulsed pressure variation as a predictor of fluid responsiveness. Intensive Care Med. 2010;36(3):496-503. doi:10.1007/s00134-009-1686-y. (Prospective interventional; 57 patients)
105. Perner A, Haase N, Wiis J, et al. Central venous oxygen saturation for the diagnosis of low cardiac output in septic shock patients. Acta Anaesthesiol Scand. 2010;54(1):98-102. doi:10.1111/j.1399-6576.2009.02086.x. (Prospective observational; 56 patients)
106. Weinbroum AA, Biderman P, Soffer D, et al. Reliability of cardiac output calculation by the fick principle and central venous oxygen saturation in emergency conditions. J Clin Monit Comput. 2008;22(5):361-366. doi:10.1007/s10877-008- 9143-y. (Prospective observational; 15 patients)
107. Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739- 746. doi:10.1001/jama.2010.158. (Prospective, randomized, controlled; 300 patients)
108. Lopez M, Sessler DI, Walter K, et al. Rate and gender dependence of the sweating, vasoconstriction, and shivering thresholds in humans. Anesthesiology. 1994;80(4):780-788. (Prospective interventional; 16 patients)
109. Leslie K, Sessler DI. Perioperative hypothermia in the high-risk surgical patient. Best Pract Res Clin Anaesthesiol. 2003;17(4):485-498. (Review)
110. De Witte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anesthesiology. 2002;96(2):467-484. (Review)
111. Chamorro C, Borrallo JM, Romera MA, et al. Anesthesia and analgesia protocol during therapeutic hypothermia after cardiac arrest: a systematic review. Anesth Analg. 2010;110(5):1328-1335. doi:10.1213/ANE.0b013e3181d8cacf. (Systematic review)
112. Wadhwa A, Sengupta P, Durrani J, et al. Magnesium sulphate only slightly reduces the shivering threshold in humans. Br J Anaesth. 2005;94(6):756-762. doi:10.1093/bja/ aei105. (Prospective, randomized, controlled; 9 patients)
113. Zweifler RM, Voorhees ME, Mahmood MA, et al. Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort. Stroke. 2004;35(10):2331-2334. doi:10.1161/01.STR.0000141161.63181.f1. (Prospective interventional; 22 patients)
114. Kimberger O, Ali SZ, Markstaller M, et al. Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study. Crit Care. 2007;11(1):R29. doi:10.1186/ cc5709. (Prospective interventional; 80 patients)
115. Matsukawa T, Kurz A, Sessler DI, et al. Propofol linearly reduces the vasoconstriction and shivering thresholds. Anesthesiology. 1995;82(5):1169-1180. (Prospective interventional; 5 patients)
116. Talke P, Tayefeh F, Sessler DI, et al. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology. 1997;87(4):835-841. (Prospective, randomized, interventional; 9 patients)
117. Cheung KW, Green RS, Magee KD. Systematic review of randomized controlled trials of therapeutic hypothermia as a neuroprotectant in post cardiac arrest patients. CJEM. 2006;8(5):329-337. (Systematic review)
118. Lavinio A, Timofeev I, Nortje J, et al. Cerebrovascular reactivity during hypothermia and rewarming. Br J Anaesth. 2007;99(2):237-244. doi:10.1093/bja/aem118. (Prospective observational; 118 patients)
119. Alam HB, Rhee P, Honma K, et al. Does the rate of rewarming from profound hypothermic arrest influence the outcome in a swine model of lethal hemorrhage? J Trauma. 2006;60(1):134-146. doi:10.1097/01.ta.0000198469.95292.ec. (Animal model)
120. Maxwell WL, Watson A, Queen R, et al. Slow, medium, or fast re-warming following post-traumatic hypothermia therapy? An ultrastructural perspective. J Neurotrauma. 2005;22(8):873-884. doi:10.1089/neu.2005.22.873. (Animal model)
121. Kawahara F, Kadoi Y, Saito S, et al. Slow rewarming improves jugular venous oxygen saturation during rewarming. Acta Anaesthesiol Scand. 2003;47(4):419-424. (Prospective, randomized, controlled; 100 patients)
122. Polderman KH, Peerdeman SM, Girbes AR. Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg. 2001;94(5):697-705. doi:10.3171/jns.2001.94.5.0697. (Prospective observational; 41 patients)